Patient-reported outcomes following abiraterone acetate plus prednisone added to androgen deprivation therapy in patients with newly diagnosed metastatic castration-naive prostate cancer (LATITUDE): an international, randomised phase 3 trial

Publication | Closed Access

DOI

163

Citations

References

2018

Year

Kim N., Andrew Protheroe, Gaetano Facchini, Henrik Suttman, Nobuaki Matsubara, Zhangqun Ye, Bhumsuk Keam, Ronaldo Damião, Tracy Li, Kelly McQuarrie,

The Lancet Oncology

Patient-reported OutcomesUrologyGenitourinary CancerDeprivation TherapyMedicineRandomised Phase 3Cancer ManagementClinical TrialsOutcomes ResearchProstatic DiseaseOncology